Figure 3
From: Cardiac safety analysis of anti-HER2-targeted therapy in early breast cancer
ROC curves of hs-TnI and QTc for the diagnosis of cardiotoxicity.
Figure 3 | Scientific Reports
From: Cardiac safety analysis of anti-HER2-targeted therapy in early breast cancer
ROC curves of hs-TnI and QTc for the diagnosis of cardiotoxicity.
